Page last updated: 2024-10-31

n(1),n(11)-diethylnorspermine and Demyelinating Diseases

n(1),n(11)-diethylnorspermine has been researched along with Demyelinating Diseases in 1 studies

N(1),N(11)-diethylnorspermine: structure given in first source

Demyelinating Diseases: Diseases characterized by loss or dysfunction of myelin in the central or peripheral nervous system.

Research Excerpts

ExcerptRelevanceReference
"This 52-year-old male without a significant medical history was receiving chemotherapy with diethylnorspermine (DENSPM), a polyamine analogue, for a partially resected pancreatic adenocarcinoma."3.70Chemotherapy for pancreatic cancer: a neuroimaging clinicopathologic correlation. ( Rojiani, AM; Valenstein, EJ; Williams, LS, 1999)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rojiani, AM1
Williams, LS1
Valenstein, EJ1

Other Studies

1 other study available for n(1),n(11)-diethylnorspermine and Demyelinating Diseases

ArticleYear
Chemotherapy for pancreatic cancer: a neuroimaging clinicopathologic correlation.
    Journal of neuroimaging : official journal of the American Society of Neuroimaging, 1999, Volume: 9, Issue:3

    Topics: Adenocarcinoma; Antineoplastic Agents; Brain; Brain Neoplasms; Demyelinating Diseases; Diagnosis, Di

1999